HB 233 takes positive steps toward updating Montana law to cover biologics and biosimilars in a way that protects patients. Unlike traditional chemical drugs, biologics are unique, complex structures made from living cells that are not easily replicated. A small change or difference in the biosimilar or biologic manufacturing process has the potential to adversely impact the patient. […]
FOR IMMEDIATE RELEASE MEDIA CONTACT Jessica Daitch Phone: 917-816-6712 Email: [email protected] Survey Finds Insurance Companies are Forcing Floridians Off Prescribed Medications During the Plan Year, Providing A Need for New Legislation to Fix the Problem Nearly all respondents (94%) support legislation prohibiting insurance companies from financially pressuring them to switch from their prescribed medication UPPER […]
Global Healthy Living Foundation’s Director of State and National Advocacy, Stephen Marmaras, recently was interviewed on the radio in Alaska to discuss recent biosimilar legislation and its implications for Alaskans.
Director of State and National Advocacy, Stephen Marmaras, commented on off label uses of medications on November 9th, 2016. He acknowledges the promise to patients off label usage offers, as well as the disparity of education between large medical centers and more isolated rural providers. Marmaras proposes further distribution of peer reviewed articles for education, […]
We want to share a quick update and applaud one of our 50-State Network advocates Danielle Yevsa who spoke up about Fail First/ Step Therapy practices in the New York Daily News.